John Gunn - Dodge & Cox
Holding/activity history for AstraZeneca PLC (AZN)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 57,474 | 0.01 | Reduce 5.03% | <0.01 | $197.22 | $11,335,022 | SEC |
| 2025 Q4 | 60,521 | 0.01 | Reduce 11.96% | <0.01 | $183.86 | $11,127,483 | SEC |
| 2025 Q3 | 68,744 | 0.01 | $153.44 | $10,548,079 | SEC | ||
| 2025 Q2 | 68,744 | 0.01 | Add 0.99% | <0.01 | $139.76 | $9,607,661 | SEC |
| 2025 Q1 | 68,070 | 0.01 | Reduce 5.27% | <0.01 | $147.00 | $10,006,290 | SEC |
| 2024 Q4 | 71,855 | 0.01 | Reduce 3.57% | <0.01 | $131.04 | $9,415,879 | SEC |
| 2024 Q3 | 74,517 | 0.01 | Reduce 0.50% | <0.01 | $155.82 | $11,611,317 | SEC |
| 2024 Q2 | 74,892 | 0.01 | Reduce 3.54% | <0.01 | $155.98 | $11,681,732 | SEC |
| 2024 Q1 | 77,642 | 0.01 | Reduce 0.25% | $135.50 | $10,520,559 | SEC | |
| 2023 Q4 | 77,837 | 0.01 | Reduce 1.05% | <0.01 | $134.70 | $10,484,711 | SEC |
| 2023 Q3 | 78,662 | 0.01 | Reduce 19.97% | <0.01 | $135.44 | $10,654,049 | SEC |
| 2023 Q2 | 98,287 | 0.01 | Reduce 12.02% | <0.01 | $143.14 | $14,068,873 | SEC |
| 2023 Q1 | 111,712 | 0.01 | Reduce 27.54% | <0.01 | $138.82 | $15,507,929 | SEC |
| 2022 Q4 | 154,162 | 0.01 | Reduce 20.20% | <0.01 | $135.60 | $20,904,435 | SEC |
| 2022 Q3 | 193,182 | 0.02 | Reduce 23.11% | <0.01 | $109.68 | $21,188,000 | SEC |
| 2022 Q2 | 251,244 | 0.02 | Reduce 37.72% | 0.01 | $132.14 | $33,199,000 | SEC |
| 2022 Q1 | 403,413 | 0.03 | Reduce 1.35% | <0.01 | $132.68 | $53,525,000 | SEC |
| 2021 Q4 | 408,947 | 0.03 | Reduce 3.08% | <0.01 | $116.50 | $47,642,000 | SEC |
| 2021 Q3 | 421,932 | 0.03 | Reduce 3.45% | <0.01 | $120.12 | $50,683,000 | SEC |
| 2021 Q2 | 437,013 | 0.03 | Reduce 1.83% | <0.01 | $119.80 | $52,354,000 | SEC |
| 2021 Q1 | 445,138 | 0.03 | Reduce 73.15% | 0.10 | $99.44 | $44,265,000 | SEC |
| 2020 Q4 | 1,657,586 | 0.13 | Reduce 77.63% | 0.58 | $99.98 | $165,725,000 | SEC |
| 2020 Q3 | 7,410,673 | 0.75 | Reduce 21.06% | 0.19 | $109.60 | $812,210,000 | SEC |
| 2020 Q2 | 9,387,881 | 0.92 | Reduce 37.17% | 0.54 | $105.78 | $993,050,000 | SEC |
| 2020 Q1 | 14,941,519 | 1.45 | Reduce 22.33% | 0.33 | $89.32 | $1,334,576,000 | SEC |
| 2019 Q4 | 19,237,465 | 1.47 | Reduce 22.04% | 0.40 | $99.72 | $1,918,360,000 | SEC |
| 2019 Q3 | 24,674,570 | 1.82 | Add 0.02% | <0.01 | $89.14 | $2,199,491,000 | SEC |
| 2019 Q2 | 24,668,481 | 1.65 | Reduce 0.16% | <0.01 | $82.56 | $2,036,630,000 | SEC |
| 2019 Q1 | 24,707,100 | 1.65 | Reduce 0.21% | <0.01 | $80.86 | $1,997,816,000 | SEC |
| 2018 Q4 | 24,758,200 | 1.73 | Reduce 3.18% | 0.05 | $75.96 | $1,880,633,000 | SEC |
| 2018 Q3 | 25,570,154 | 1.56 | Reduce 3.10% | 0.05 | $79.14 | $2,023,622,000 | SEC |
| 2018 Q2 | 26,387,404 | 1.51 | Reduce 3.22% | 0.05 | $70.22 | $1,852,924,000 | SEC |
| 2018 Q1 | 27,265,089 | 1.58 | Reduce 3.54% | 0.06 | $69.94 | $1,906,920,000 | SEC |
| 2017 Q4 | 28,265,489 | 1.56 | Add 0.59% | <0.01 | $69.40 | $1,961,625,000 | SEC |
| 2017 Q3 | 28,100,089 | 1.57 | Reduce 0.83% | 0.01 | $67.76 | $1,904,062,000 | SEC |
| 2017 Q2 | 28,334,724 | 1.67 | Reduce 0.42% | <0.01 | $68.18 | $1,931,862,000 | SEC |
| 2017 Q1 | 28,453,249 | 1.54 | Add 14.70% | 0.20 | $62.28 | $1,772,068,000 | SEC |
| 2016 Q4 | 24,806,794 | 1.23 | Add 17.60% | 0.18 | $54.64 | $1,355,443,000 | SEC |
| 2016 Q3 | 21,094,986 | 1.33 | Add 29.68% | 0.30 | $65.72 | $1,386,363,000 | SEC |
| 2016 Q2 | 16,266,361 | 1.01 | Add 24.89% | 0.20 | $60.38 | $982,163,000 | SEC |
| 2016 Q1 | 13,024,825 | 0.75 | Add 121.19% | 0.41 | $56.32 | $733,558,000 | SEC |
| 2015 Q4 | 5,888,566 | 0.41 | Buy | 0.41 | $67.90 | $399,834,000 | SEC |